PDCD1 and melanoma: T cell immunoglobulin and mucin domain 3 (TIM-3) and T cell immunoreceptor with Ig and ITIM domains (TIGIT) are two extensively studied immune checkpoints responsible for fortifying melanoma against current immunotherapies, especially anti-PD-1 treatments (47) and [reviewed in (48–51)].